ROME THERAPEUTICS
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning.
ROME THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2020-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.rometx.com
Total Employee:
11+
Status:
Active
Total Funding:
127 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
Dracen Pharmaceuticals
Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Genomic Prediction
Genomic Prediction provides advanced genetic testing for IVF.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Regenosine, Inc
Regenosine is developing a first-in-class disease-modifying regenerative therapy for osteoarthritis.
Royal Emerald Pharmaceuticals
Royal Emerald Pharmaceuticals produces non-addictive alternate medicines for dilemmas of PTSD and other health consequences.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
VasoRx
VasoRx is developing RNA therapies for diseases of the cardiovascular system & oncology such as atherosclerosis and pulmonary hypertension.
Zucara Therapeutics
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.
Current Advisors List
Current Employees Featured
Founder
Investors List
Section 32
Section 32 investment in Series B - ROME Therapeutics
Mass General Brigham Ventures
Mass General Brigham Ventures investment in Series B - ROME Therapeutics
Andreessen Horowitz
Andreessen Horowitz investment in Series B - ROME Therapeutics
Casdin Capital
Casdin Capital investment in Series B - ROME Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - ROME Therapeutics
GV
GV investment in Series B - ROME Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - ROME Therapeutics
Sanofi Ventures
Sanofi Ventures investment in Series B - ROME Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series A - ROME Therapeutics
GV
GV investment in Series A - ROME Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-26 | ROME Therapeutics Appoints Nurjana Bachman, Ph.D., as Senior Vice President, Corporate Development and Strategy |
Official Site Inspections
http://www.rometx.com Semrush global rank: 3.29 M Semrush visits lastest month: 4.97 K
- Host name: 149.51.237.35.bc.googleusercontent.com
- IP address: 35.237.51.149
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
